登录后查看消息通知
搜索
常见问题
消息
登录
首页
/
数据集
/
Addressing high costs of specialty drugs
Addressing high costs of specialty drugs
收藏
Organisation for Economic Co-operation and Development
2026-04-11 收录
专科药物成本控制
药品定价分析
数据链接：
https://www.oecd.org/en/publications/addressing-high-costs-of-specialty-drugs_4cf3224f-en.html
数据链接
链接失效反馈
官方服务：
问题咨询
购买咨询
在线客服
NEW
资源简介：
Addressing high costs of specialty drugs
应用场景：
相关数据集
Humira U.S. price change 2021-2022
药品定价分析
生物制药市场
Humira price change in the U.S. between 2019 and 2022
Statista
9
0
Price comparison of most expensive drugs U.S. 2025
药品定价分析
高价值药物市场
Most expensive drugs in the United States as of 2025 (in million U.S. dollars)
Statista
8
0
Median MPRs for OBs and LPGs in the public and private sectors.
药品定价分析
制药市场
OBs: Originator brands; LPGs: Lowest-priced generics; NEML: National Essential Medicine List (2009).
NIAID Data Ecosystem
5
0
Lisinopril out-of-pocket cost U.S. 2004-2023
药品定价分析
医疗费用负担
Lisinopril out-of-pocket cost in the U.S. from 2004 to 2023 (in U.S. dollars)
Statista
8
0
Modeling HIV/AIDS Drug Price Determinants in Brazil: Is Generic Competition a Myth?
药品定价分析
仿制药市场竞争
BackgroundBrazil became the first developing country to guarantee free and universal access to HIV/AIDS treatment, with antiretroviral drugs (ARVs) being delivered to nearly 190,000 patients. The anal
NIAID Data Ecosystem
7
0
© 2023-2026 上海数据发展科技有限责任公司 版权所有
沪ICP备17003045号-15
沪公网安备31010402336585号
热门搜索
社区交流群
科研交流群
商业服务
数据资源
寻源服务
数据采集
标注服务
数据产品
代理销售
数据领域
凭证登记
数据产品
介绍推广
